Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 229

1.

Strategies for a Successful Anatomic Pathology Subspecialty Workgroup: The 26-Year Collaboration of "The Elves".

International Liver Pathology Study Group.

Acad Pathol. 2016 Jun 27;3:2374289516653766. doi: 10.1177/2374289516653766. eCollection 2016 Jan-Dec.

2.

p53 Expression as a Diagnostic Biomarker in Ulcerative Colitis-Associated Cancer.

Kobayashi K, Tomita H, Shimizu M, Tanaka T, Suzui N, Miyazaki T, Hara A.

Int J Mol Sci. 2017 Jun 16;18(6). pii: E1284. doi: 10.3390/ijms18061284. Review.

3.

Low-Grade Colorectal Dysplasia and the Need for Colectomy.

Ullman TA.

Gastroenterol Hepatol (N Y). 2006 Dec;2(12):868-870. No abstract available.

4.

Pseudopolyps in inflammatory bowel diseases: Have we learned enough?

Politis DS, Katsanos KH, Tsianos EV, Christodoulou DK.

World J Gastroenterol. 2017 Mar 7;23(9):1541-1551. doi: 10.3748/wjg.v23.i9.1541. Review.

5.

Plecanatide-mediated activation of guanylate cyclase-C suppresses inflammation-induced colorectal carcinogenesis in Apc+/Min-FCCC mice.

Chang WL, Masih S, Thadi A, Patwa V, Joshi A, Cooper HS, Palejwala VA, Clapper ML, Shailubhai K.

World J Gastrointest Pharmacol Ther. 2017 Feb 6;8(1):47-59. doi: 10.4292/wjgpt.v8.i1.47.

6.

Clinical usefulness of narrow band imaging magnifying colonoscopy for assessing ulcerative colitis-associated cancer/dysplasia.

Nishiyama S, Oka S, Tanaka S, Sagami S, Hayashi R, Ueno Y, Arihiro K, Chayama K.

Endosc Int Open. 2016 Nov;4(11):E1183-E1187.

7.

Common Inflammatory Disorders and Neoplasia of the Ileal Pouch: A Review of Histopathology.

Gonzalo DH, Collinsworth AL, Liu X.

Gastroenterology Res. 2016 Jun;9(2-3):29-38. Epub 2016 Jun 18. Review.

8.

Biomarkers for colitis-associated colorectal cancer.

Chen R, Lai LA, Brentnall TA, Pan S.

World J Gastroenterol. 2016 Sep 21;22(35):7882-91. doi: 10.3748/wjg.v22.i35.7882. Review.

9.

Expression Profile of p53 and p21 in Large Bowel Mucosa as Biomarkers of Inflammatory-Related Carcinogenesis in Ulcerative Colitis.

Popp C, Nichita L, Voiosu T, Bastian A, Cioplea M, Micu G, Pop G, Sticlaru L, Bengus A, Voiosu A, Mateescu RB.

Dis Markers. 2016;2016:3625279. doi: 10.1155/2016/3625279. Epub 2016 Aug 7.

10.

Diagnostic yield of endomicroscopy for dysplasia in primary sclerosing cholangitis associated inflammatory bowel disease: a feasibility study.

Dlugosz A, Barakat AM, Björkström NK, Öst Å, Bergquist A.

Endosc Int Open. 2016 Aug;4(8):E901-11. doi: 10.1055/s-0042-111203. Epub 2016 Aug 5.

11.

Ulcerative colitis associated with nephrotic syndrome after treatment with mesalazine developed into rectal carcinoma: a case study.

Sameshima S, Koketsu S, Okuyama T, Kubota Y, Ono Y, Noie T, Oya M.

World J Surg Oncol. 2016 Jul 22;14(1):192. doi: 10.1186/s12957-016-0950-1.

12.

Study of p53 and bcl-2 Oncoproteins in Ulcerative Colitis with Dysplasia.

Kinra P, Turlapati S, Mehta A, Rai R.

Med J Armed Forces India. 2005 Feb;61(2):125-9. doi: 10.1016/S0377-1237(05)80006-1. Epub 2011 Jul 21.

13.

Critical function of the necroptosis adaptor RIPK3 in protecting from intestinal tumorigenesis.

Bozec D, Iuga AC, Roda G, Dahan S, Yeretssian G.

Oncotarget. 2016 Jul 19;7(29):46384-46400. doi: 10.18632/oncotarget.10135.

14.

Incidence of neoplasias and effectiveness of postoperative surveillance endoscopy for patients with ulcerative colitis: comparison of ileorectal anastomosis and ileal pouch-anal anastomosis.

Ishii H, Hata K, Kishikawa J, Anzai H, Otani K, Yasuda K, Nishikawa T, Tanaka T, Tanaka J, Kiyomatsu T, Kawai K, Nozawa H, Kazama S, Yamaguchi H, Ishihara S, Sunami E, Kitayama J, Watanabe T.

World J Surg Oncol. 2016 Mar 9;14:75. doi: 10.1186/s12957-016-0833-5.

15.

Inflammatory bowel disease associated neoplasia: A surgeon's perspective.

Althumairi AA, Lazarev MG, Gearhart SL.

World J Gastroenterol. 2016 Jan 21;22(3):961-73. doi: 10.3748/wjg.v22.i3.961. Review.

16.

Diagnosis and therapies for gastric non-invasive neoplasia.

Kato M.

World J Gastroenterol. 2015 Nov 28;21(44):12513-8. doi: 10.3748/wjg.v21.i44.12513. Review.

17.
18.

Endoscopic Therapy in Inflammatory Bowel Diseases.

Neumann H, Neurath MF, Atreya R.

Viszeralmedizin. 2015 Aug;31(4):280-6. doi: 10.1159/000435851. Epub 2015 Aug 4. Review.

19.

Expression of p53 predicts risk of prevalent and incident advanced neoplasia in patients with Barrett's esophagus and epithelial changes indefinite for dysplasia.

Horvath B, Singh P, Xie H, Thota PN, Sun X, Liu X.

Gastroenterol Rep (Oxf). 2016 Nov;4(4):304-309. Epub 2015 Oct 19.

20.

Inflammation decreases keratin level in ulcerative colitis; inadequate restoration associates with increased risk of colitis-associated cancer.

Corfe BM, Majumdar D, Assadsangabi A, Marsh AM, Cross SS, Connolly JB, Evans CA, Lobo AJ.

BMJ Open Gastroenterol. 2015 May 18;2(1):e000024. doi: 10.1136/bmjgast-2014-000024. eCollection 2015.

Supplemental Content

Support Center